158 related articles for article (PubMed ID: 21616431)
1. Safety and efficacy of radiofrequency ablation for hepatocellular adenoma.
van Vledder MG; van Aalten SM; Terkivatan T; de Man RA; Leertouwer T; Ijzermans JN
J Vasc Interv Radiol; 2011 Jun; 22(6):787-93. PubMed ID: 21616431
[TBL] [Abstract][Full Text] [Related]
2. Prospective study of a 'popping' sound during percutaneous radiofrequency ablation for hepatocellular carcinoma.
Fernandes ML; Lin CC; Lin CJ; Chen WT; Lin SM
J Vasc Interv Radiol; 2010 Feb; 21(2):237-44. PubMed ID: 20031448
[TBL] [Abstract][Full Text] [Related]
3. [Hepatocellular adenoma treated with radiofrequency ablation in young male].
Kim TY; Kim BS; Hyun CL; Song BC
Korean J Gastroenterol; 2011 Jun; 57(6):384-7. PubMed ID: 21694493
[No Abstract] [Full Text] [Related]
4. MR-guided radiofrequency ablation of hepatocellular carcinoma: long-term effectiveness.
Clasen S; Rempp H; Boss A; Schmidt D; Fritz J; Schraml C; Schick F; Claussen CD; Pereira PL
J Vasc Interv Radiol; 2011 Jun; 22(6):762-70. PubMed ID: 21530311
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous radiofrequency ablation of hepatocellular adenoma: initial experience in 10 patients.
Rhim H; Lim HK; Kim YS; Choi D
J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 2):e422-7. PubMed ID: 17944897
[TBL] [Abstract][Full Text] [Related]
6. Should fat in the radiofrequency ablation zone of hepatocellular adenomas raise suspicion for residual tumour?
Costa AF; Kajal D; Pereira A; Atri M
Eur Radiol; 2017 Apr; 27(4):1704-1712. PubMed ID: 27436025
[TBL] [Abstract][Full Text] [Related]
7. Single-session combined therapy with chemoembolization and radiofrequency ablation in hepatocellular carcinoma less than or equal to 5 cm: a preliminary study.
Kang SG; Yoon CJ; Jeong SH; Kim JW; Lee SH; Lee KH; Kim YH
J Vasc Interv Radiol; 2009 Dec; 20(12):1570-7. PubMed ID: 19879777
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of multiple hepatocellular adenomas with percutaneous radiofrequency ablation.
Ahn SY; Park SY; Kweon YO; Tak WY; Bae HI; Cho SH
World J Gastroenterol; 2013 Nov; 19(42):7480-6. PubMed ID: 24259982
[TBL] [Abstract][Full Text] [Related]
9. Biochemical and hematologic changes after percutaneous radiofrequency ablation of liver tumors: experience in 83 procedures.
Cizginer S; Tatli S; Hurwitz S; Tuncali K; vanSonnenberg E; Silverman SG
J Vasc Interv Radiol; 2011 Apr; 22(4):471-8. PubMed ID: 21463756
[TBL] [Abstract][Full Text] [Related]
10. Management of liver adenomatosis by radiofrequency ablation.
van Aalten SM; Terkivatan T; van der Linden E; Verheij J; de Man RA; Ijzermans JN
Dig Surg; 2011; 28(3):173-7. PubMed ID: 21540605
[TBL] [Abstract][Full Text] [Related]
11. Metformin associated with lower mortality in diabetic patients with early stage hepatocellular carcinoma after radiofrequency ablation.
Chen TM; Lin CC; Huang PT; Wen CF
J Gastroenterol Hepatol; 2011 May; 26(5):858-65. PubMed ID: 21251068
[TBL] [Abstract][Full Text] [Related]
12. Protecting the ureter during radiofrequency ablation of renal cell cancer: a pilot study of retrograde pyeloperfusion with cooled dextrose 5% in water.
Cantwell CP; Wah TM; Gervais DA; Eisner BH; Arellano R; Uppot RN; Samir AE; Irving HC; McGovern F; Mueller PR
J Vasc Interv Radiol; 2008 Jul; 19(7):1034-40. PubMed ID: 18589317
[TBL] [Abstract][Full Text] [Related]
13. Conservative and operative management of benign solid hepatic tumours: a successful stratified algorithm.
Dardenne S; Hubert C; Sempoux C; Annet L; Jouret-Mourin A; Horsmans Y; Van Beers BE; Zech F; Gigot JF
Eur J Gastroenterol Hepatol; 2010 Nov; 22(11):1337-44. PubMed ID: 20683192
[TBL] [Abstract][Full Text] [Related]
14. Management of hepatocellular adenoma during pregnancy.
Noels JE; van Aalten SM; van der Windt DJ; Kok NF; de Man RA; Terkivatan T; Ijzermans JN
J Hepatol; 2011 Mar; 54(3):553-8. PubMed ID: 21094555
[TBL] [Abstract][Full Text] [Related]
15. Stage progression of small hepatocellular carcinoma after radical therapy: comparisons of radiofrequency ablation and surgery using the Markov model.
Ikeda K; Kobayashi M; Kawamura Y; Imai N; Seko Y; Hirakawa M; Hosaka T; Sezaki H; Akuta N; Saitoh S; Suzuki F; Suzuki Y; Arase Y; Kumada H
Liver Int; 2011 May; 31(5):692-9. PubMed ID: 21457441
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous radiofrequency thermoablation as an alternative to surgery for treatment of liver tumour recurrence after hepatectomy.
Elias D; De Baere T; Smayra T; Ouellet JF; Roche A; Lasser P
Br J Surg; 2002 Jun; 89(6):752-6. PubMed ID: 12027986
[TBL] [Abstract][Full Text] [Related]
17. CT-guided radiofrequency ablation for hepatocellular carcinomas that were undetectable at US: therapeutic effectiveness and safety.
Park BJ; Byun JH; Jin YH; Won HJ; Shin YM; Kim KW; Park SJ; Kim PN
J Vasc Interv Radiol; 2009 Apr; 20(4):490-9. PubMed ID: 19328427
[TBL] [Abstract][Full Text] [Related]
18. Comparison of therapeutic effects between radiofrequency ablation and percutaneous microwave coagulation therapy for small hepatocellular carcinomas.
Ohmoto K; Yoshioka N; Tomiyama Y; Shibata N; Kawase T; Yoshida K; Kuboki M; Yamamoto S
J Gastroenterol Hepatol; 2009 Feb; 24(2):223-7. PubMed ID: 18823439
[TBL] [Abstract][Full Text] [Related]
19. Tolerance of radiofrequency ablation by patients of hepatocellular carcinoma.
Cheung TT; Ng KK; Poon RT; Fan ST
J Hepatobiliary Pancreat Surg; 2009; 16(5):655-60. PubMed ID: 19370304
[TBL] [Abstract][Full Text] [Related]
20. [Benign tumors of the liver: how to recognize them and what to do].
D'Amico DF; Zanus G; Tedeschi U
Ann Ital Chir; 1997; 68(3 Suppl):1-80. PubMed ID: 9522512
[No Abstract] [Full Text] [Related]
[Next] [New Search]
